W. Pardridge, Drug Targeting to the Brain, Pharmaceutical Research, vol.20, issue.9, pp.1733-1745, 2007.
DOI : 10.1007/s11095-007-9324-2

S. Ohtsuki and T. Terasaki, Contribution of Carrier-Mediated Transport Systems to the Blood???Brain Barrier as a Supporting and Protecting Interface for the Brain; Importance for CNS Drug Discovery and Development, Pharmaceutical Research, vol.25, issue.4, pp.1745-1758, 2007.
DOI : 10.1007/s11095-007-9374-5

T. Terasaki, S. Ohtsuki, S. Hori, H. Takanaga, E. Nakashima et al., New approaches to in vitro models of blood???brain barrier drug transport, Drug Discovery Today, vol.8, issue.20, pp.945-954, 2003.
DOI : 10.1016/S1359-6446(03)02858-7

P. Naik and L. Cucullo, In Vitro Blood???Brain Barrier Models: Current and Perspective Technologies, Journal of Pharmaceutical Sciences, vol.101, issue.4, pp.1337-1354, 2012.
DOI : 10.1002/jps.23022

B. Weksler, E. Subileau, N. Perrière, P. Charneau, K. Holloway et al., Blood-brain barrier-specific properties of a human adult brain endothelial cell line, The FASEB Journal, vol.19, pp.1872-1874, 2005.
DOI : 10.1096/fj.04-3458fje

R. Shawahna, Y. Uchida, X. Declèves, S. Ohtsuki, S. Yousif et al., Transcriptomic and Quantitative Proteomic Analysis of Transporters and Drug Metabolizing Enzymes in Freshly Isolated Human Brain Microvessels, Molecular Pharmaceutics, vol.8, issue.4, pp.1332-1341, 2011.
DOI : 10.1021/mp200129p

W. Loscher and H. Potschka, Blood-brain barrier active efflux transporters: ATP-binding cassette gene family, NeuroRX, vol.10, issue.Suppl 23, pp.86-98, 2005.
DOI : 10.1602/neurorx.2.1.86

S. Carl, D. Lindley, P. Couraud, B. Weksler, I. Romero et al., ABC and SLC Transporter Expression and Pot Substrate Characterization across the Human CMEC/D3 Blood???Brain Barrier Cell Line, Molecular Pharmaceutics, vol.7, issue.4, pp.1057-1068, 2010.
DOI : 10.1021/mp900178j

T. Okura, A. Hattori, Y. Takano, T. Sato, M. Hammarlund-udenaes et al., Involvement of the Pyrilamine Transporter, a Putative Organic Cation Transporter, in Blood-Brain Barrier Transport of Oxycodone, Drug Metabolism and Disposition, vol.36, issue.10, pp.2005-2013, 2008.
DOI : 10.1124/dmd.108.022087

M. Sadiq, A. Borgs, T. Okura, K. Shimomura, S. Kato et al., Diphenhydramine Active Uptake at the Blood???Brain Barrier and Its Interaction with Oxycodone in vitro and in Vivo, Journal of Pharmaceutical Sciences, vol.100, issue.9, pp.3912-3923, 2011.
DOI : 10.1002/jps.22567

E. Boström, U. Simonsson, and M. Hammarlund-udenaes, In Vivo Blood-Brain Barrier Transport of Oxycodone in the Rat: Indications for Active Influx and Implications for Pharmacokinetics/Pharmacodynamics, Drug Metabolism and Disposition, vol.34, issue.9, pp.1624-1631, 2006.
DOI : 10.1124/dmd.106.009746

P. André, M. Debray, J. Scherrmann, and S. Cisternino, Antiporter that Interacts with Addictive Drugs, Journal of Cerebral Blood Flow & Metabolism, vol.292, issue.7, pp.1293-1304, 2009.
DOI : 10.1038/nature03720

K. Kuwayama, H. Inoue, T. Kanamori, K. Tsujikawa, H. Miyaguchi et al., Uptake of 3,4-methylenedioxymethamphetamine and its related compounds by a proton-coupled transport system in Caco-2 cells, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1778, issue.1, pp.42-50, 2008.
DOI : 10.1016/j.bbamem.2007.08.023

T. Okura, S. Kato, Y. Takano, T. Sato, A. Yamashita et al., Functional characterization of Rat Plasma Membrane Monoamine Transporter in the Blood???Brain and Blood???Cerebrospinal Fluid Barriers, Journal of Pharmaceutical Sciences, vol.100, issue.9, pp.3924-3938, 2011.
DOI : 10.1002/jps.22594

Y. Takasato, S. Rapoport, and Q. Smith, An in situ brain perfusion technique to study cerebrovascular transport in rats, Am J Physiol, vol.247, pp.484-493, 1984.

K. Selinger, J. Prevost, and H. Hill, High-performance liquid chromatography method for the determination of diphenhydramine in human plasma, Journal of Chromatography B: Biomedical Sciences and Applications, vol.526
DOI : 10.1016/S0378-4347(00)82546-3

C. Webb and M. Eldon, Sensitive high-performance liquid chromatographic (HPLC) determination of diphenhydramine in plasma using fluorescence detection, Pharmaceutical Research, vol.08, issue.11, pp.1448-1451, 1991.
DOI : 10.1023/A:1015821811634

M. Yamazaki, H. Fukuoka, O. Nagata, H. Kato, Y. Ito et al., Transport Mechanism of an H1-Antagonist at the Blood-Brain Barrier: Transport Mechanism of Mepyramine Using the Carotid Injection Technique., Biological & Pharmaceutical Bulletin, vol.17, issue.5, pp.676-679, 1994.
DOI : 10.1248/bpb.17.676

B. Poller, H. Gutmann, S. Krähenbühl, B. Weksler, I. Romero et al., The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies, Journal of Neurochemistry, vol.876, issue.5
DOI : 10.1111/j.1471-4159.2008.05730.x

Y. Nakazawa, T. Okura, K. Shimomura, T. Terasaki, and Y. Deguchi, Drug???drug interaction between oxycodone and adjuvant analgesics in blood???brain barrier transport and antinociceptive effect, Journal of Pharmaceutical Sciences, vol.99, issue.1, pp.467-474, 2010.
DOI : 10.1002/jps.21807

T. Okura, R. Ito, N. Ishiguro, I. Tamai, and Y. Deguchi, Blood???brain barrier transport of pramipexole, a dopamine D2 agonist, Life Sciences, vol.80, issue.17, pp.1564-1571, 2007.
DOI : 10.1016/j.lfs.2007.01.035

S. Kooijmans, D. Senyschyn, M. Mezhiselvam, J. Morizzi, S. Charman et al., -Dependent Transporter in the Brain Uptake of Amantadine and Rimantadine, Molecular Pharmaceutics, vol.9, issue.4, pp.883-893, 2012.
DOI : 10.1021/mp2004127

Z. Szabo, H. Ravert, I. Gozukara, W. Geckle, and C. Seki, Noncompartmental and compartmental modeling of the kinetics of carbon-11 labeled pyrilamine in the human brain, Synapse, vol.16, issue.4, pp.263-275, 1993.
DOI : 10.1002/syn.890150403

. Shimomura, Functional expression of a protoncoupled organic cation (H + /OC) antiporter in human brain capillary endothelial cell line hCMEC/D3, a human blood?brain barrier model. Fluids and Barriers of the CNS, p.8, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00785327